Riley L. Svec

1.0k total citations · 1 hit paper
7 papers, 812 citations indexed

About

Riley L. Svec is a scholar working on Organic Chemistry, Molecular Biology and Genetics. According to data from OpenAlex, Riley L. Svec has authored 7 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Riley L. Svec's work include Catalytic Cross-Coupling Reactions (2 papers), Glioma Diagnosis and Treatment (2 papers) and Nanomaterials for catalytic reactions (2 papers). Riley L. Svec is often cited by papers focused on Catalytic Cross-Coupling Reactions (2 papers), Glioma Diagnosis and Treatment (2 papers) and Nanomaterials for catalytic reactions (2 papers). Riley L. Svec collaborates with scholars based in United States. Riley L. Svec's co-authors include Paul J. Hergenrother, Alfredo García, Tomohiro Shirai, Michelle F. Richter, Bryon Drown, Andrew P. Riley, Daniel G. Olson, David Šarlah, Timothy M. Fan and Gregory J. Riggins and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Riley L. Svec

7 papers receiving 798 citations

Hit Papers

Predictive compound accumulation rules yield a broad-spec... 2017 2026 2020 2023 2017 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riley L. Svec United States 6 351 258 239 137 100 7 812
Laure Maigre France 16 191 0.5× 248 1.0× 160 0.7× 93 0.7× 86 0.9× 22 656
Jarrod W. Johnson Canada 14 357 1.0× 286 1.1× 130 0.5× 114 0.8× 73 0.7× 26 890
Ana Amoroso Belgium 14 302 0.9× 157 0.6× 135 0.6× 82 0.6× 39 0.4× 33 704
Manuka Ghosh United States 15 314 0.9× 271 1.1× 137 0.6× 91 0.7× 86 0.9× 21 654
Takeshi Murata Japan 16 327 0.9× 281 1.1× 167 0.7× 107 0.8× 42 0.4× 56 854
Wanida Phetsang Australia 11 198 0.6× 155 0.6× 95 0.4× 89 0.6× 66 0.7× 18 453
Yanan Hu United States 11 682 1.9× 97 0.4× 392 1.6× 200 1.5× 82 0.8× 16 1.0k
Laura C. Miller United States 11 630 1.8× 222 0.9× 391 1.6× 55 0.4× 100 1.0× 13 1.1k
Jalal Haddad United States 13 559 1.6× 217 0.8× 184 0.8× 96 0.7× 66 0.7× 15 864
L. Moynié United Kingdom 15 516 1.5× 408 1.6× 72 0.3× 146 1.1× 59 0.6× 25 1.0k

Countries citing papers authored by Riley L. Svec

Since Specialization
Citations

This map shows the geographic impact of Riley L. Svec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riley L. Svec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riley L. Svec more than expected).

Fields of papers citing papers by Riley L. Svec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riley L. Svec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riley L. Svec. The network helps show where Riley L. Svec may publish in the future.

Co-authorship network of co-authors of Riley L. Svec

This figure shows the co-authorship network connecting the top 25 collaborators of Riley L. Svec. A scholar is included among the top collaborators of Riley L. Svec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riley L. Svec. Riley L. Svec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Svec, Riley L., et al.. (2022). Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture. ACS Chemical Biology. 17(2). 299–313. 13 indexed citations
2.
Svec, Riley L. & Paul J. Hergenrother. (2019). Imidazotetrazines as Weighable Diazomethane Surrogates for Esterifications and Cyclopropanations. Angewandte Chemie. 132(5). 1873–1878. 8 indexed citations
3.
Svec, Riley L. & Paul J. Hergenrother. (2019). Imidazotetrazines as Weighable Diazomethane Surrogates for Esterifications and Cyclopropanations. Angewandte Chemie International Edition. 59(5). 1857–1862. 22 indexed citations
4.
Svec, Riley L., et al.. (2018). Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma. ACS Chemical Biology. 13(11). 3206–3216. 27 indexed citations
5.
Olson, Daniel G., et al.. (2018). Enantioselective Synthesis of Isocarbostyril Alkaloids and Analogs Using Catalytic Dearomative Functionalization of Benzene. Journal of the American Chemical Society. 141(1). 657–670. 68 indexed citations
6.
Richter, Michelle F., Bryon Drown, Andrew P. Riley, et al.. (2017). Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 545(7654). 299–304. 671 indexed citations breakdown →
7.
Sletten, Eric T., Riley L. Svec, & Hien M. Nguyen. (2015). Synthesis of a polymerizable, bivalent glycan mimetic of the HIV envelope spike gp120. Tetrahedron Letters. 56(23). 3473–3476. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026